December 20, 2017 / 12:26 PM / 5 months ago

BRIEF-Taris And Bristol-Myers Squibb Announce Clinical Trial Collaboration

Dec 20 (Reuters) - Bristol-Myers Squibb Co:

* TARIS AND BRISTOL-MYERS SQUIBB ANNOUNCE CLINICAL TRIAL COLLABORATION

* BRISTOL-MYERS SQUIBB - ‍IN CONJUNCTION WITH COLLABORATION, CO ALSO MADE AN EQUITY INVESTMENT IN TARIS​

* BRISTOL-MYERS SQUIBB CO - ‍PHASE 1B STUDY TO COMBINE TAR-200 (GEMRIS) WITH OPDIVO (NIVOLUMAB) IN TREATMENT OF MUSCLE INVASIVE BLADDER CANCER​ Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below